Treatment of neurolept-induced tardive dyskinesia

被引:39
作者
Jankelowitz, Stacey K. [1 ]
机构
[1] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia
关键词
tardive dyskinesia; treatment; neuroleptic agents; PLACEBO-CONTROLLED TRIAL; DEEP BRAIN-STIMULATION; SCHIZOPHRENIA SPECTRUM DISORDERS; HYPERKINETIC MOVEMENT-DISORDERS; GENETIC ASSOCIATION ANALYSIS; VITAMIN-E TREATMENT; OPEN-LABEL TRIAL; 1A2; CYP1A2; GENE; DOUBLE-BLIND; RECEPTOR GENE;
D O I
10.2147/NDT.S30767
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tardive dyskinesia (TDK) includes orobuccolingual movements and "piano-playing" movements of the limbs. It is a movement disorder of delayed onset that can occur in the setting of neuroleptic treatment as well as in other diseases and following treatment with other drugs. The specific pathophysiology resulting in TDK is still not completely understood but possible mechanisms include postsynaptic dopamine receptor hypersensitivity, abnormalities of striatal gamma-aminobutyric acid (GABA) neurons, and degeneration of striatal cholinergic interneurons. More recently, the theory of synaptic plasticity has been proposed. Considering these proposed mechanisms of disease, therapeutic interventions have attempted to manipulate dopamine, GABA, acetylcholine, norepinephrine and serotonin pathways and receptors. The data for the effectiveness of each class of drugs and the side effects were considered in turn.
引用
收藏
页码:1371 / 1380
页数:10
相关论文
共 50 条
[21]   Tardive dyskinesia update: treatment and management [J].
Owens, David Cunningham .
BJPSYCH ADVANCES, 2019, 25 (02) :78-89
[22]   Treatment of tardive dyskinesia: A systematic review (1997-2011) [J].
Alimi, M. ;
Gaillard, P. ;
Camus, V. ;
El-Hage, W. .
EUROPEAN JOURNAL OF PSYCHIATRY, 2013, 27 (03) :160-173
[23]   Oxidative stress and tardive dyskinesia: Pharmacogenetic evidence [J].
Cho, Chul-Hyun ;
Lee, Heon-Jeong .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 46 :207-213
[24]   Melatonin for the treatment of tardive dyskinesia [J].
Nelson, LA ;
McGuire, JM ;
Hausafus, SN .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (7-8) :1128-1131
[25]   Tardive Dyskinesia [J].
Aia, Pratibha G. ;
Revuelta, Gonzalo J. ;
Cloud, Leslie J. ;
Factor, Stewart A. .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2011, 13 (03) :231-241
[26]   Tetrabenazine for the Treatment of Tardive Dyskinesia [J].
Leung, Jonathan G. ;
Breden, Ericka L. .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) :525-531
[27]   Deep Brain Stimulation in the Treatment of Tardive Dyskinesia [J].
Szczakowska, Adrianna ;
Gabryelska, Agata ;
Gawlik-Kotelnicka, Oliwia ;
Strzelecki, Dominik .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
[28]   A new era in the diagnosis and treatment of tardive dyskinesia [J].
Caroff, Stanley N. ;
Cutler, Andrew J. .
CNS SPECTRUMS, 2023, 28 (04) :401-415
[29]   Treatment Strategies for Tardive Dyskinesia [J].
Kremens, Daniel E. .
JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (01)
[30]   Tardive Dyskinesia: Treatment Update [J].
Divya Arya ;
Tarannum Khan ;
Adam J. Margolius ;
Hubert H. Fernandez .
Current Neurology and Neuroscience Reports, 2019, 19